Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously

This publication has 31 references indexed in Scilit:

• Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial.
  Journal of Clinical Oncology, 1991
• Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor.
  1990
• Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.
  Journal of Clinical Investigation, 1990
• PHASE-I STUDY OF INTRAVENOUSLY ADMINISTERED BACTERIALLY SYNTHESIZED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND COMPARISON WITH SUBCUTANEOUS ADMINISTRATION
  1990
• Granulocyte-Macrophage Colony-Stimulating Factor: Pleiotropic Cytokine with Potential Clinical Usefulness
  Clinical Infectious Diseases, 1990
• Amelioration of Chemotherapy-Induced Thrombocytopenia by GM-CSF: Apparent Dose and Schedule Dependency
  JNCI Journal of the National Cancer Institute, 1989
• GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
  The Lancet, 1989
• Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions – a phase I dose-toxicity study
  British Journal of Cancer, 1989
• PHARMACOKINETICS OF HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR USING A SENSITIVE IMMUNOASSAY
  1988
• PRODUCTION OF INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA AND TUMOR NECROSIS FACTOR BY HUMAN MONONUCLEAR-CELLS STIMULATED WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
  1988